Next generation sequencing of a wide variety of cancers, including melanoma, chronic lymphocytic leukemia, angiosarcomas and gliomas, has identified recurrent somatic mutations in hPOT1, suggesting that hPOT1 functions as an important tumor suppressor (25,26). This evidence concerns the gene POT1 and cancer.